These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1091 related articles for article (PubMed ID: 20152549)
21. Pharmacy cost evaluation of risperidone, olanzapine, and quetiapine for the treatment of schizophrenia in acute care inpatient settings. Mladsi DM; Grogg AL; Irish WD; Lopez RB; Degen K; Swann A; Nimsch CT Curr Med Res Opin; 2004 Dec; 20(12):1883-93. PubMed ID: 15701206 [TBL] [Abstract][Full Text] [Related]
22. Time to discontinuation of atypical versus typical antipsychotics in the naturalistic treatment of schizophrenia. Ascher-Svanum H; Zhu B; Faries D; Landbloom R; Swartz M; Swanson J BMC Psychiatry; 2006 Feb; 6():8. PubMed ID: 16504026 [TBL] [Abstract][Full Text] [Related]
23. Antipsychotic treatment discontinuation in previously untreated patients with schizophrenia: 36-month results from the SOHO study. Haro JM; Novick D; Suarez D; Roca M J Psychiatr Res; 2009 Jan; 43(3):265-73. PubMed ID: 18644606 [TBL] [Abstract][Full Text] [Related]
24. Drug prescription patterns in schizophrenia outpatients: analysis of data from a German health insurance fund. Weinbrenner S; Assion HJ; Stargardt T; Busse R; Juckel G; Gericke CA Pharmacopsychiatry; 2009 Mar; 42(2):66-71. PubMed ID: 19308881 [TBL] [Abstract][Full Text] [Related]
25. [Effectiveness of antipsychotics in schizophrenia and related disorders. Results of a naturalistic study]. Carpiniello B; Mellino G; Pintore S; Puddu L; Pinna F Clin Ter; 2011; 162(4):331-41. PubMed ID: 21912821 [TBL] [Abstract][Full Text] [Related]
26. Persistence of Antipsychotic Use After Clozapine Discontinuation: A Real-World Study Across Antipsychotics. Stam N; Taipale H; Tanskanen A; Isphording L; Okhuijsen-Pfeifer C; Schuiling-Veninga CCM; Bos JHJ; Bijker BJ; Tiihonen J; Luykx JJ Clin Transl Sci; 2020 Nov; 13(6):1170-1177. PubMed ID: 32441836 [TBL] [Abstract][Full Text] [Related]
27. Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003. Morrato EH; Dodd S; Oderda G; Haxby DG; Allen R; Valuck RJ Clin Ther; 2007 Jan; 29(1):183-95. PubMed ID: 17379060 [TBL] [Abstract][Full Text] [Related]
28. Intent-to-treat analysis of health care expenditures of patients treated with atypical antipsychotics as adjunctive therapy in depression. Jing Y; Kalsekar I; Curkendall SM; Carls GS; Bagalman E; Forbes RA; Hebden T; Thase ME Clin Ther; 2011 Sep; 33(9):1246-57. PubMed ID: 21840058 [TBL] [Abstract][Full Text] [Related]
29. Rate of new-onset diabetes among patients treated with atypical or conventional antipsychotic medications for schizophrenia. Ollendorf DA; Joyce AT; Rucker M MedGenMed; 2004 Jan; 6(1):5. PubMed ID: 15208518 [TBL] [Abstract][Full Text] [Related]
31. Comparison of incidence rates of cerebrovascular accidents and transient ischaemic attacks in observational cohort studies of patients prescribed risperidone, quetiapine or olanzapine in general practice in England including patients with dementia. Layton D; Harris S; Wilton LV; Shakir SA J Psychopharmacol; 2005 Sep; 19(5):473-82. PubMed ID: 16166184 [TBL] [Abstract][Full Text] [Related]
32. The impact of atypical antipsychotic medications on the use of health care by patients with schizophrenia. Chen L; McCombs JS; Park J Value Health; 2008; 11(1):34-43. PubMed ID: 18237358 [TBL] [Abstract][Full Text] [Related]
33. Estimating the Impact of Adherence to and Persistence with Atypical Antipsychotic Therapy on Health Care Costs and Risk of Hospitalization. Jiang Y; Ni W Pharmacotherapy; 2015 Sep; 35(9):813-22. PubMed ID: 26406773 [TBL] [Abstract][Full Text] [Related]
35. Patient characteristics and prescription patterns of atypical antipsychotics among patients with schizophrenia. Ren XS; Kazis LE; Lee AF; Hamed A; Huang YH; Cunningham F; Miller DR J Clin Pharm Ther; 2002 Dec; 27(6):441-51. PubMed ID: 12472984 [TBL] [Abstract][Full Text] [Related]
36. An algorithm-based approach to first-episode schizophrenia: response rates over 3 prospective antipsychotic trials with a retrospective data analysis. Agid O; Arenovich T; Sajeev G; Zipursky RB; Kapur S; Foussias G; Remington G J Clin Psychiatry; 2011 Nov; 72(11):1439-44. PubMed ID: 21457676 [TBL] [Abstract][Full Text] [Related]
37. From conventional to atypical antipsychotics and back: dynamic processes in the diffusion of new medications. Leslie DL; Rosenheck RA Am J Psychiatry; 2002 Sep; 159(9):1534-40. PubMed ID: 12202274 [TBL] [Abstract][Full Text] [Related]
38. Time to psychiatric hospitalization in patients with bipolar disorder treated with a mood stabilizer and adjunctive atypical antipsychotics: a retrospective claims database analysis. Kim E; Maclean R; Ammerman D; Jing Y; Pikalov A; You M; Van-Tran Q; L'Italien G Clin Ther; 2009 Apr; 31(4):836-48. PubMed ID: 19446157 [TBL] [Abstract][Full Text] [Related]
39. Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia. Sernyak MJ; Leslie DL; Alarcon RD; Losonczy MF; Rosenheck R Am J Psychiatry; 2002 Apr; 159(4):561-6. PubMed ID: 11925293 [TBL] [Abstract][Full Text] [Related]
40. Increase in mortality rate in patients with dementia treated with atypical antipsychotics: a cohort study in outpatients in Central Italy. Piersanti M; Capannolo M; Turchetti M; Serroni N; De Berardis D; Evangelista P; Costantini P; Orsini A; Rossi A; Maggio R Riv Psichiatr; 2014; 49(1):34-40. PubMed ID: 24572582 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]